We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Cigna (CI) Q3 Earnings Beat on Higher Enrollment, Guides Up
Read MoreHide Full Article
Cigna Corp. (CI - Free Report) reported third-quarter 2017 earnings per share of $2.83, beating the Zacks Consensus Estimate of $2.36. Earnings also grew 46% year over year.
Better-than-expected earnings were primarily driven by broad-based growth across its business segments.
Other Details
Cigna posted revenues of $10.27 billion, which surpassed the Zacks Consensus Estimate of $10.13 billion. Revenues grew 4.7% year over year.
Total benefits and expenses of $9.6 billion increased 5% year over year. Operating expense ratio of 21.1% improved 100 basis points year over year.
Premium were up 5.6% year over year to $8 billion, while fees increased 4.7% to $1.14 billion.
The company medical enrollment grew to 15.82 million from 15.18 million in the year-ago quarter, driven by growth in its Commercial market segments.
Cigna Corporation Price, Consensus and EPS Surprise
Global Health Care: Premiums and fees from the segment increased 6% year over year to $7.2 billion. The improvement was driven by customer growth and specialty contributions in the Commercial employer group. However, the upside was partially offset by reductions in Government customers.
Adjusted operating earnings were $575 million, up 38.2% year over year on strong medical and specialty results, and continued effective medical cost.
Global Supplemental Benefits: Premiums and fees from this segment climbed 12.5% year over year to $937 million on the back of continued business growth.
Adjusted operating income increased 34.6% year over year to $109 million, reflecting business growth, favorable claims experience, particularly in South Korea, and effective operating expense management.
Global Disability and Life: Premiums and fees decreased 0.9% year over year to $1.02 billion.
The segment reported adjusted operating income of $73 million, up 37.8% year over year, reflecting a favorable claims experience in life business.
Financial Position
Cash and cash equivalents were $3.66 billion at Sep 30, 2017, up from $3.19 billion at year-end 2016.
Cigna’s long-term debt of $5.21 billion as of Sep 30, 2017 increased from $4.76 billion as of Dec 31, 2016.
Year to date, the company has repurchased 13.2 million shares of common stock for approximately $2.3 billion.
2017 Guidance Increase
Cigna pulled up its 2017 earnings guidance after strong results. It expects adjusted income from operations of $2.60 billion to $2.65 billion (previous estimate was $2.50 billion to $2.58 billion), or $10.20 to $10.40 per share ($9.75-$10.05 previously).
The company expects a revenue growth rate of approximately 4% and global medical customer growth of nearly 0.65 million.
Our Take
Cigna’s results reflect broad-based growth across its business segments. The company is poised for long-term growth on the back of its robust Global Supplemental business, growing government business and increasing membership. A strong capital position and resumption of share buyback are the other positives. The company has also been successful in maintaining its medical cost ratio at low levels.
Zacks Rank and Performance of Other Insurers
Currently, Cigna carries a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
Among the other firms in the health care sector that have reported their second-quarter earnings so far, the bottom line at Aetna Inc. , Humana Inc. (HUM - Free Report) and UnitedHealth Group Inc. (UNH - Free Report) beat their respective Zacks Consensus Estimate.
Zacks’ Best Private Investment Ideas
While we are happy to share many articles like this on the website, our best recommendations and most in-depth research are not available to the public.
Starting today, for the next month, you can follow all Zacks' private buys and sells in real time. Our experts cover all kinds of trades… from value to momentum . . . from stocks under $10 to ETF and option moves . . . from stocks that corporate insiders are buying up to companies that are about to report positive earnings surprises. You can even look inside exclusive portfolios that are normally closed to new investors.
Image: Bigstock
Cigna (CI) Q3 Earnings Beat on Higher Enrollment, Guides Up
Cigna Corp. (CI - Free Report) reported third-quarter 2017 earnings per share of $2.83, beating the Zacks Consensus Estimate of $2.36. Earnings also grew 46% year over year.
Better-than-expected earnings were primarily driven by broad-based growth across its business segments.
Other Details
Cigna posted revenues of $10.27 billion, which surpassed the Zacks Consensus Estimate of $10.13 billion. Revenues grew 4.7% year over year.
Total benefits and expenses of $9.6 billion increased 5% year over year.
Operating expense ratio of 21.1% improved 100 basis points year over year.
Premium were up 5.6% year over year to $8 billion, while fees increased 4.7% to $1.14 billion.
The company medical enrollment grew to 15.82 million from 15.18 million in the year-ago quarter, driven by growth in its Commercial market segments.
Cigna Corporation Price, Consensus and EPS Surprise
Cigna Corporation Price, Consensus and EPS Surprise | Cigna Corporation Quote
Strong Segment Performance
Global Health Care: Premiums and fees from the segment increased 6% year over year to $7.2 billion. The improvement was driven by customer growth and specialty contributions in the Commercial employer group. However, the upside was partially offset by reductions in Government customers.
Adjusted operating earnings were $575 million, up 38.2% year over year on strong medical and specialty results, and continued effective medical cost.
Global Supplemental Benefits: Premiums and fees from this segment climbed 12.5% year over year to $937 million on the back of continued business growth.
Adjusted operating income increased 34.6% year over year to $109 million, reflecting business growth, favorable claims experience, particularly in South Korea, and effective operating expense management.
Global Disability and Life: Premiums and fees decreased 0.9% year over year to $1.02 billion.
The segment reported adjusted operating income of $73 million, up 37.8% year over year, reflecting a favorable claims experience in life business.
Financial Position
Cash and cash equivalents were $3.66 billion at Sep 30, 2017, up from $3.19 billion at year-end 2016.
Cigna’s long-term debt of $5.21 billion as of Sep 30, 2017 increased from $4.76 billion as of Dec 31, 2016.
Year to date, the company has repurchased 13.2 million shares of common stock for approximately $2.3 billion.
2017 Guidance Increase
Cigna pulled up its 2017 earnings guidance after strong results. It expects adjusted income from operations of $2.60 billion to $2.65 billion (previous estimate was $2.50 billion to $2.58 billion), or $10.20 to $10.40 per share ($9.75-$10.05 previously).
The company expects a revenue growth rate of approximately 4% and global medical customer growth of nearly 0.65 million.
Our Take
Cigna’s results reflect broad-based growth across its business segments. The company is poised for long-term growth on the back of its robust Global Supplemental business, growing government business and increasing membership. A strong capital position and resumption of share buyback are the other positives. The company has also been successful in maintaining its medical cost ratio at low levels.
Zacks Rank and Performance of Other Insurers
Currently, Cigna carries a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
Among the other firms in the health care sector that have reported their second-quarter earnings so far, the bottom line at Aetna Inc. , Humana Inc. (HUM - Free Report) and UnitedHealth Group Inc. (UNH - Free Report) beat their respective Zacks Consensus Estimate.
Zacks’ Best Private Investment Ideas
While we are happy to share many articles like this on the website, our best recommendations and most in-depth research are not available to the public.
Starting today, for the next month, you can follow all Zacks' private buys and sells in real time. Our experts cover all kinds of trades… from value to momentum . . . from stocks under $10 to ETF and option moves . . . from stocks that corporate insiders are buying up to companies that are about to report positive earnings surprises. You can even look inside exclusive portfolios that are normally closed to new investors.
Click here for Zacks' private trades >>